Back to Authors

Matthews, Emma

https://orcid.org/0000-0002-3810-306X

Mayo Clinic

National Hospital for Neurology and Neurosurgery

Citations 2

Prevalence and Phenotypic Correlations of Calmodulinopathy-Causative CALM1-3 Variants Detected in a Multicenter Molecular Autopsy Cohort of Sudden Unexplained Death Victims
Clemens, Daniel J. , Gray, Belinda , Tester, David J. , Giudicessi, John R. , Maleszewski, Joseph J. , Crotti, Lia , Schwartz, Peter J. , Matthews, Emma , Semsarian, Christopher , Behr, Elijah R. , Ackerman, Michael J. , Schwartz, Peter J. , Crotti, Lia , Behr, Elijah Raphael , Gray, Belinda , Bagnall, Richard D

Circulation: Genomic and Precision Medicine | November 15, 2020 | Volume: 13 | Issue: 6 | Pages: No page available

10.1161/circgen.120.003032 Get It

Triadin Knockout Syndrome Is Absent in a Multi-Center Molecular Autopsy Cohort of Sudden Infant Death Syndrome and Sudden Unexplained Death in the Young and Is Extremely Rare in the General Population
Clemens, Daniel J. , Gray, Belinda , Tester, David J. , Dotzler, Steven M. , Giudicessi, John R. , Matthews, Emma , Semsarian, Christopher , Behr, Elijah R. , Ackerman, Michael J. , Behr, Elijah Raphael , Gray, Belinda , Bagnall, Richard D

Circulation: Genomic and Precision Medicine | April 21, 2020 | Volume: 13 | Issue: 2 | Pages: No page available

10.1161/circgen.119.002731 Get It

Background: Triadin knockout syndrome (TKOS) is a potentially lethal arrhythmia disorder caused by recessively inherited null variants in TRDN -encoded cardiac triadin. Despite its malignant phenotype, the prevalence of TKOS in sudden infant death syndrome and sudden unexplained death in the young is unknown. Methods: Exome sequencing was performed on 599 sudden infant death syndrome and 258 sudden unexplained death in the young cases. Allele frequencies of all TRDN null variants identified in the cardiac-specific isoform of TRDN in the Genome Aggregation Database were used to determine the estimated prevalence and ethnic distribution of TKOS. Results: No triadin null individuals were identified in 599 sudden infant death syndrome and 258 sudden unexplained death in the young exomes. Using the Genome Aggregation Database, we estimate the overall prevalence of TKOS to be ≈1:22.7 million individuals. However, TKOS prevalence is 5.5-fold higher in those of African descent (≈1:4.1 million). Conclusions: TKOS is an exceedingly rare clinical entity that does not contribute meaningfully to either sudden infant death syndrome or sudden unexplained death in the young. However, despite its rarity and absence in large sudden death cohorts, TKOS remains a malignant and potentially lethal disorder which requires further research to better care for these patients.